Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Shouhui Yang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102251392. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2016: 3 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 7

  1. ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer. Co-author DOI 10.1002/ijc.34960↗
  2. SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2023.113434↗
  3. Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients. Co-author DOI 10.1093/carcin/bgac092↗
  4. NO• /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer. Co-author DOI 10.1002/ijc.32733↗
  5. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Co-author DOI 10.1158/0008-5472.can-15-2841↗
  6. Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer. First author DOI 10.1158/1078-0432.ccr-16-0511↗
  7. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. Co-author DOI 10.18632/oncotarget.10323↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nader N Hanna · 7 shared papers, 2016–2024 · strength 0.71
  2. Jochen Gaedcke · 7 shared papers, 2016–2024 · strength 0.71
  3. S. Perwez Hussain · 7 shared papers, 2016–2024 · strength 0.71
  4. Azadeh Azizian · 4 shared papers, 2020–2024 · strength 0.56
  5. Yuuki Ohara · 3 shared papers, 2022–2024 · strength 0.47
  6. Β. Michael Ghadimi · 5 shared papers, 2016–2022 · strength 0.37
  7. Paloma Moreno · 2 shared papers, 2023–2024 · strength 0.34
  8. Michael B. Ghadimi · 2 shared papers, 2023–2024 · strength 0.34
  9. Jian Wang · 4 shared papers, 2016–2020 · strength 0.24
  10. H. Richard Alexander · 4 shared papers, 2016–2020 · strength 0.24
  11. Matthias M. Gaida · 4 shared papers, 2016–2020 · strength 0.24
  12. Dong Ho Lee · 2 shared papers, 2016–2020 · strength 0.14
  13. Lin Zhang · 1 shared paper, 2022 · strength 0.13
  14. Limin Wang · 1 shared paper, 2020 · strength 0.09
  15. Dong Ki Lee · 1 shared paper, 2016 · strength 0.05
  16. Naotake Funamizu · 1 shared paper, 2016 · strength 0.05
  17. Tadashi Uwagawa · 1 shared paper, 2016 · strength 0.05
  18. Katsuhiko K. Yanaga · 1 shared paper, 2016 · strength 0.05
  19. Jens Werner · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.